Valley Childrens Hospital
- Type
- Teaching hospital
- Where
- MADERA, CA
- Medicare CCN
- 053300
- Received
- $171,833 in 38 records, 2025 ($30,665 general, $141,168 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit: VALLEY CHILDRENS HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 19 | $30,665 |
| 2025 | Research payment | 19 | $141,168 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 4 | $65,803 | 2025 |
| Genentech, Inc. | 6 | $36,153 | 2025 |
| Novartis Pharmaceuticals Corporation | 4 | $12,786 | 2025 |
| MED-EL Corporation | 1 | $9,090 | 2025 |
| Abbott Laboratories | 1 | $8,950 | 2025 |
| SpringWorks Therapeutics, Inc. | 3 | $7,500 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $6,500 | 2025 |
| HEMA Biologics, LLC | 1 | $5,675 | 2025 |
| Neurelis, Inc. | 3 | $5,500 | 2025 |
| PFIZER INC. | 1 | $4,800 | 2025 |
| Sarepta Therapeutics, Inc. | 1 | $1,500 | 2025 |
| NS Pharma, Inc. | 1 | $1,500 | 2025 |
| Siemens Medical Solutions USA, Inc. | 1 | $1,224 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,000 | 2025 |
| Alexion Pharmaceuticals, Inc. | 1 | $1,000 | 2025 |
| Incyte Corporation | 1 | $1,000 | 2025 |
| JAZZ PHARMACEUTICALS INC. | 1 | $900 | 2025 |
| SANOFI-AVENTIS U.S. LLC | 1 | $750 | 2025 |
| Stryker Corporation | 1 | $118 | 2025 |
| Bio-Rad Laboratories, Inc. | 2 | $38 | 2025 |
| Smith+Nephew, Inc. | 1 | $30 | 2025 |
| WERFEN USA LLC | 1 | $13 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $141,168 |
| Grant | 5 | $10,500 |
| Long term medical supply or device loan | 3 | $10,344 |
| Education | 3 | $5,500 |
| Space rental or facility fees (teaching hospital only) | 3 | $3,150 |
| Gift | 1 | $1,000 |
| Debt forgiveness | 4 | $170 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Stryker Corporation | $118 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-03 | SpringWorks Therapeutics, Inc. | $2,500 | Grant | Cash or cash equivalent | GOMEKLI Drug | 2025 | |
| 2025-11-05 | PFIZER INC. | $4,800 | Research payment | Cash or cash equivalent | LORBRENA Drug, ONCOLOGY | ANBL1531 LORLATINIB ARM A PHASE 3 STUDY OF 131IMETAIODOBENZYLGUANIDINE 131IMIBG OR ALK INHIBITOR THERAPY ADDED TO INTEN | 2025 |
| 2025-10-25 | VERTEX PHARMACEUTICALS INCORPORATED | $6,500 | Research payment | Cash or cash equivalent | A Non-Interventional Study Evaluating the Impact of TRIKAFTA Initiation on 2- to 5-Year-Olds With Cystic Fibrosis and Th | 2025 | |
| 2025-10-22 | Genentech, Inc. | $633 | Research payment | Cash or cash equivalent | Evrysdi Drug, Neurology | LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT | 2025 |
| 2025-10-02 | ABBVIE INC. | $416 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | Pilot Study of Venetoclax in Combination with Conventional Chemotherapy in Pediatric Patients with Acute Myeloid Leukemi | 2025 |
| 2025-10-01 | Novartis Pharmaceuticals Corporation | $150 | Research payment | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy | 2025 |
| 2025-09-25 | WERFEN USA LLC | $13 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-08-20 | Siemens Medical Solutions USA, Inc. | $1,224 | Long term medical supply or device loan | In-kind items and services | 2025 | ||
| 2025-07-24 | SpringWorks Therapeutics, Inc. | $2,500 | Grant | Cash or cash equivalent | GOMEKLI Drug | 2025 | |
| 2025-07-17 | Smith+Nephew, Inc. | $30 | Long term medical supply or device loan | In-kind items and services | ACUFEX Device, Sports Med Shoulder | 2025 | |
| 2025-07-16 | Genentech, Inc. | $1,899 | Research payment | Cash or cash equivalent | LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT | 2025 | |
| 2025-07-09 | Novartis Pharmaceuticals Corporation | $3,360 | Research payment | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy | 2025 |
| 2025-06-25 | MED-EL Corporation | $9,090 | Long term medical supply or device loan | In-kind items and services | Mi1250 SYNCHRONY 2 FLEXsoft Device, Cochlear Implant | 2025 | |
| 2025-05-22 | SpringWorks Therapeutics, Inc. | $2,500 | Grant | Cash or cash equivalent | GOMEKLI Drug | 2025 | |
| 2025-05-15 | HEMA Biologics, LLC | $5,675 | Research payment | Cash or cash equivalent | SEVENFACT Drug, HEMATOLOGY | Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT | 2025 |
| 2025-05-14 | E.R. Squibb & Sons, L.L.C. | $1,000 | Research payment | Cash or cash equivalent | Risk adapted, response based Phase 2 trial of nivolumab and brentuximab vedotin followed by brentuximab vedotin and bend | 2025 | |
| 2025-04-26 | Novartis Pharmaceuticals Corporation | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | 2025 | |
| 2025-04-24 | Alexion Pharmaceuticals, Inc. | $1,000 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-04-22 | Sarepta Therapeutics, Inc. | $1,500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-04-18 | Bio-Rad Laboratories, Inc. | $19 | Debt forgiveness | Cash or cash equivalent | Liquichek Device, Controls | 2025 | |
| 2025-04-18 | Bio-Rad Laboratories, Inc. | $19 | Debt forgiveness | Cash or cash equivalent | Lipid Transfection Reagents Device, Not Applicable | 2025 | |
| 2025-04-16 | Neurelis, Inc. | $3,500 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-04-04 | SANOFI-AVENTIS U.S. LLC | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2025 | |
| 2025-04-02 | NS Pharma, Inc. | $1,500 | Grant | Cash or cash equivalent | VILTEPSO Drug, PEDIATRIC NEUROLOGY | 2025 | |
| 2025-04-01 | Incyte Corporation | $1,000 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2025 | |
| 2025-04-01 | Neurelis, Inc. | $1,000 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-03-17 | Neurelis, Inc. | $1,000 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-03-12 | Novartis Pharmaceuticals Corporation | $7,775 | Research payment | Cash or cash equivalent | ZOLGENSMA Drug, Neurology | A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy | 2025 |
| 2025-02-13 | Genentech, Inc. | $21,000 | Research payment | Cash or cash equivalent | Risdiplam post gene therapy study plateau symptoms study 2 | 2025 | |
| 2025-02-12 | Genentech, Inc. | $11,988 | Research payment | Cash or cash equivalent | LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT | 2025 | |
| 2025-02-12 | Genentech, Inc. | $560 | Research payment | Cash or cash equivalent | Evrysdi Drug, Neurology | Early Model for Satralizumab in Generalized Myasthenia Gravis | 2025 |
| 2025-02-12 | Genentech, Inc. | $73 | Research payment | Cash or cash equivalent | Evrysdi Drug, Neurology | Post Marketing Surveillance of VABYSMO | 2025 |
| 2025-01-30 | ABBVIE INC. | $2,082 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Blister Card: ABT-199 50mg Film-coated Tablet 1x8, 8 Tablets | 2025 |
| 2025-01-30 | ABBVIE INC. | $832 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Blister Card: ABT-199 10mg Tablet 2x8, 16 Tablets | 2025 |
| 2025-01-16 | ABBVIE INC. | $62,472 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Bottle: ABT-199 100mg Yellow Film Coated Tablet 120 Tablets | 2025 |
| 2025-01-13 | Abbott Laboratories | $8,950 | Research payment | Cash or cash equivalent | SJM MASTERS SERIES Device, Structural Heart | NCT02097420--HALO: A Single Arm Prospective Investigation of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve | 2025 |
| 2025-01-10 | JAZZ PHARMACEUTICALS INC. | $900 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Madera, CA, county Madera County, CA, state California; placed by its city name.
| Measure | Place (city or town) Madera, CA | County Madera County, CA | State California |
|---|---|---|---|
| Population B01003 | 67,831 | 160,940 | 39,287,377 |
| Population, 2020 census P1 | 66,224 | 156,255 | 39,538,223 |
| Median age B01002 | 30.4 | 34.6 | 37.9 |
| Under 18 B01001 | 30.8% | 27.1% | 22.0% |
| 65 and over B01001 | 9.6% | 14.4% | 15.7% |
| Households B11001 | 17,526 | 45,379 | 13,548,091 |
| Foreign born B05002 | 25.6% | 20.1% | 27.0% |
| Median household income B19013 | $63,933 | $76,627 | $99,122 |
| Median family income B19113 | $67,479 | $83,389 | $113,346 |
| Per capita income B19301 | $24,200 | $30,077 | $49,513 |
| Poverty rate B17001 | 25.6% | 19.2% | 12.0% |
| Unemployment rate B23025 | 12.6% | 10.1% | 6.6% |
| Civilian labor force B23025 | 29,997 | 69,012 | 20,068,466 |
| Mean commute (minutes) B08013 | 25.7 | 27.9 | 28.7 |
| Bachelor's degree or higher B15003 | 10.9% | 17.9% | 37.1% |
| Housing units B25001 | 18,562 | 51,015 | 14,644,735 |
| Owner-occupied B25003 | 54.7% | 67.5% | 55.9% |
| Renters B25003 | 45.3% | 32.5% | 44.1% |
| Median home value B25077 | $359,900 | $393,200 | $734,700 |
| Median gross rent B25064 | $1,353 | $1,390 | $2,036 |
| White, not Hispanic B03002 | 12.2% | 29.9% | 33.8% |
| Black B03002 | 2.9% | 2.4% | 5.2% |
| Hispanic or Latino B03002 | 81.1% | 60.9% | 40.2% |
| Asian B03002 | 1.3% | 2.4% | 15.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.4% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Madera, CA.
Comments